Search

everythinglearnresearchcommunity

for

Search:↓

DPCP treatment improved hair regrowth and increased new capillaries in alopecia areata patients.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

A child with a rare vitamin D-resistant condition improved with treatment.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Medication 1 improved hair quality and growth more effectively than medication 2 and the placebo.

In 2023, there were major advancements in skin and venereal disease treatments.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

UVA-1 phototherapy might help treat alopecia areata.

Antioxidants can block the cancer-fighting effects of doxorubicin.

34% of patients on hepatitis C treatment had reversible skin issues.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

The procedure involving seminal vesiculoscopy, TURED, and balloon dilation effectively treated a man's hematospermia and improved his dysorgasmia.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The method could improve vitiligo treatment by effectively delivering therapy to hair follicles.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.